Cargando…
Recent EORTC and MRC UK studies: implications for imaging ovarian cancer
For many years the primary management of newly diagnosed advanced ovarian cancer has been cytoreductive surgery followed by chemotherapy, and the mainstay of follow-up of treated women has been serial assay of serum CA-125. The findings of 2 recent research protocols have a significant effect on the...
Autores principales: | Spencer, John A., Perren, Timothy J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
e-Med
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904027/ https://www.ncbi.nlm.nih.gov/pubmed/20605760 http://dx.doi.org/10.1102/1470-7330.2010.0018 |
Ejemplares similares
-
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma: A randomized phase III Intergroup study by EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033)
por: Baumert, Brigitta G., et al.
Publicado: (2016) -
MRC2020: improvements to Ximdisp and the MRC image-processing programs
por: Short, J. M., et al.
Publicado: (2023) -
An overview in the treatment of advanced ovarian cancer. MRC Gynaecological Cancer Working Party.
Publicado: (1990) -
The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer
por: Thomas, J. S., et al.
Publicado: (2017) -
Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience.
por: Gore, M. E., et al.
Publicado: (1995)